Mesopenem

# Mesopenem ## Overview - **Classification**: Carbapenem antibiotic - **Mechanism**: Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to bacterial cell lysis and death. It has a broad spectrum of activity. ## Primary Indications 1. **Complicated Intra-abdominal Infections** - Peritonitis, appendicitis with rupture. 2. **Bacterial Meningitis** - For susceptible strains. 3. **Hospital-Acquired Pneumonia** - Including ventilator-associated pneumonia. 4. **Complicated Skin and Skin Structure Infections (cSSSI)** - Including diabetic foot infections. 5. **Febrile Neutropenia** - Empiric therapy for presumed bacterial infections. ## Adult Dosing ### Standard Dosing **Complicated Intra-abdominal Infections, cSSSI, Hospital-Acquired Pneumonia** - **Dose**: **1 gram** - **Frequency**: Every **8 hours** - **Route**: Intravenous (IV) infusion over **15-30 minutes** - **Duration**: 5-14 days, depending on infection severity and response. **Bacterial Meningitis** - **Dose**: **2 grams** - **Frequency**: Every **8 hours** - **Route**: IV infusion over **15-30 minutes** - **Duration**: 7-21 days, depending on pathogen and clinical response. **Febrile Neutropenia** - **Dose**: **1 gram** - **Frequency**: Every **8 hours** - **Route**: IV infusion over **15-30 minutes** ### Dose Adjustments - **Renal Impairment**: - CrCl **26-49 mL/min**: **1 gram** every **12 hours** - CrCl **10-25 mL/min**: **500 mg** every **12 hours** - CrCl **<10 mL/min**: **500 mg** every **24 hours** - Hemodialysis: Administer dose **after** dialysis session. - **Hepatic Impairment**: No dose adjustment generally required. - **Elderly Patients**: Dose based primarily on renal function. ## Pediatric Dosing ### Neonates (0-28 days) - **Dose**: **20 mg/kg** - **Frequency**: Every **12 hours** - **Maximum**: Adhere to mg/kg dosing; no fixed maximum. - **Special Notes**: Consider prolonged infusion (e.g., 3 hours) for severe infections. ### Infants (1-12 months) - **Dose**: **20 mg/kg** - **Frequency**: Every **8 hours** - **Maximum**: Do not exceed adult dose of **1 gram** per dose. - **Special Notes**: For meningitis, **40 mg/kg** every **8 hours** (max **2 g**/dose). ### Children (1-12 years) - **Dose**: **20 mg/kg** - **Frequency**: Every **8 hours** - **Maximum**: Equivalent to adult dose of **1 gram** per dose. - **Special Notes**: For meningitis, **40 mg/kg** every **8 hours** (max **2 g**/dose). ### Adolescents (13-18 years) - **Dose**: Generally follow **adult dosing** guidelines. - **Maximum**: **2 grams** per dose for meningitis, otherwise **1 gram** per dose. ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to meropenem or other carbapenem antibiotics. - **Absolute**: Severe hypersensitivity (e.g., anaphylaxis) to any beta-lactam antibiotic. ### Common Adverse Effects - **Very Common (>10%)**: Diarrhea, Nausea/Vomiting, Headache. - **Common (1-10%)**: Rash, Injection site reactions, Constipation, Anemia. - **Serious but Rare**: Seizures, Anaphylaxis, Clostridium difficile-associated diarrhea (CDAD), Stevens-Johnson Syndrome (SJS). ### Key Drug Interactions - **Valproic Acid/Divaproex**: **Decreased** valproic acid levels, risking loss of seizure control. Avoid co-administration. - **Probenecid**: **Increases** meropenem plasma concentration and prolongs half-life. Not recommended concurrently. - **Oral Anticoagulants (e.g., Warfarin)**: May **potentiate** anticoagulant effects. Monitor INR/PT closely. ## Monitoring & Follow-up - **Before Treatment**: Obtain cultures (if appropriate) and baseline renal function (CrCl). - **During Treatment**: Monitor for signs of superinfection (e.g., CDAD). Periodically assess renal function, CBC, and LFTs. - **Clinical Signs**: Observe for allergic reactions, seizures (especially in renal impairment), and worsening infection. ## Clinical Pearls - 💡 **Tip 1**: Meropenem is a **broad-spectrum** antibiotic often reserved for severe, resistant, or polymicrobial infections. - 💡 **Tip 2**: For meningitis, the **higher dose** is critical for adequate penetration into the central nervous system. - 💡 **Tip 3**: Administer via **IV infusion** (15-30 min) to minimize injection site reactions and risk of seizures. - 💡 **Tip 4**: Counsel patients to immediately report any **severe or bloody diarrhea** due to the risk of CDAD. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.